(WELL) Welltower - Ratings and Ratios
Seniors Housing, Wellness Communities, Outpatient Medical Buildings
WELL EPS (Earnings per Share)
WELL Revenue
Description: WELL Welltower
Welltower Inc. (NYSE: WELL) is a leading global healthcare infrastructure company operating in the seniors and wellness housing sector, with a portfolio of over 1,500 communities across the United States, United Kingdom, and Canada. The company focuses on creating vibrant communities for mature renters and older adults, while also supporting physicians in outpatient medical buildings by providing critical infrastructure.
From a financial perspective, Welltowers market capitalization stands at approximately $99.9 billion USD, indicating a significant presence in the market. The companys Price-to-Earnings (P/E) ratio is around 86.80, suggesting a relatively high valuation compared to its earnings. Additionally, the forward P/E ratio is 90.91, indicating expected continued growth. The Return on Equity (RoE) is 3.46%, which may be considered relatively low, potentially indicating room for improvement in generating profits from shareholder equity.
To further analyze Welltowers performance, key performance indicators (KPIs) such as Funds From Operations (FFO) per share, occupancy rates, and rental growth rates can be considered. FFO is a crucial metric for REITs, as it provides a more accurate picture of their operating performance. A high occupancy rate and steady rental growth rate would indicate a strong operational performance. As a Healthcare REIT, Welltowers business is influenced by factors such as demographic trends, healthcare policies, and the overall state of the economy.
Welltowers unique approach to viewing itself as a product company in a real estate wrapper driven by relationships and an unconventional culture, combined with its disciplined approach to capital allocation and the Welltower Business System, positions the company for long-term growth. The companys Data Science platform is also a key factor in driving superior operating results. By leveraging these strengths, Welltower aims to deliver long-term compounding of per-share growth and returns for its investors.
WELL Stock Overview
| Market Cap in USD | 111,654m |
| Sub-Industry | Health Care REITs |
| IPO / Inception | 2001-01-02 |
WELL Stock Ratings
| Growth Rating | 89.3% |
| Fundamental | 63.8% |
| Dividend Rating | 51.5% |
| Return 12m vs S&P 500 | 19.7% |
| Analyst Rating | 4.30 of 5 |
WELL Dividends
| Dividend Yield 12m | 1.76% |
| Yield on Cost 5y | 5.50% |
| Annual Growth 5y | -1.06% |
| Payout Consistency | 97.5% |
| Payout Ratio | 143.4% |
WELL Growth Ratios
| Growth Correlation 3m | 85.1% |
| Growth Correlation 12m | 90.7% |
| Growth Correlation 5y | 84.8% |
| CAGR 5y | 27.50% |
| CAGR/Max DD 5y | 0.67 |
| Sharpe Ratio 12m | 2.27 |
| Alpha | 32.29 |
| Beta | 0.414 |
| Volatility | 19.77% |
| Current Volume | 2114.9k |
| Average Volume 20d | 2484.6k |
| Stop Loss | 162.3 (-3%) |
| Signal | -0.06 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (1.13b TTM) > 0 and > 6% of Revenue (6% = 548.1m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 1.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 69.06% (prev 66.89%; Δ 2.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 2.61b > Net Income 1.13b (YES >=105%, WARN >=100%) |
| Net Debt (12.90b) to EBITDA (3.28b) ratio: 3.93 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (668.1m) change vs 12m ago 10.52% (target <= -2.0% for YES) |
| Gross Margin 38.71% (prev 39.16%; Δ -0.45pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 18.02% (prev 15.30%; Δ 2.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.36 (EBITDA TTM 3.28b / Interest Expense TTM 579.6m) >= 6 (WARN >= 3) |
Altman Z'' -0.01
| (A) 0.11 = (Total Current Assets 8.29b - Total Current Liabilities 1.98b) / Total Assets 55.83b |
| (B) -0.15 = Retained Earnings (Balance) -8.53b / Total Assets 55.83b |
| (C) 0.03 = EBIT TTM 1.37b / Avg Total Assets 50.68b |
| (D) -0.42 = Book Value of Equity -8.03b / Total Liabilities 19.29b |
| Total Rating: -0.01 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.78
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 2.06% = 1.03 |
| 3. FCF Margin 28.28% = 7.07 |
| 4. Debt/Equity 0.50 = 2.38 |
| 5. Debt/Ebitda 5.47 = -2.50 |
| 6. ROIC - WACC -3.80% = -4.75 |
| 7. RoE 3.42% = 0.28 |
| 8. Rev. Trend 96.96% = 4.85 |
| 9. Rev. CAGR 21.63% = 2.50 |
| 10. EPS Trend 77.09% = 1.93 |
| 11. EPS CAGR 256.4% = 2.50 |
What is the price of WELL shares?
Over the past week, the price has changed by +0.28%, over one month by +6.22%, over three months by +10.84% and over the past year by +40.84%.
Is Welltower a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WELL is around 195.40 USD . This means that WELL is currently undervalued and has a potential upside of +16.73% (Margin of Safety).
Is WELL a buy, sell or hold?
- Strong Buy: 10
- Buy: 6
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the WELL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 177.5 | 6% |
| Analysts Target Price | 166.4 | -0.6% |
| ValueRay Target Price | 214.2 | 27.9% |
Last update: 2025-08-23 05:05
WELL Fundamental Data Overview
CCE Cash And Equivalents = 4.41b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 93.2626
P/E Forward = 99.0099
P/S = 12.0345
P/B = 3.0924
P/EG = 3.6218
Beta = 0.915
Revenue TTM = 9.14b USD
EBIT TTM = 1.37b USD
EBITDA TTM = 3.28b USD
Long Term Debt = 15.97b USD (from longTermDebt, last quarter)
Short Term Debt = 1.98b USD (from totalCurrentLiabilities, last quarter)
Debt = 17.95b USD (Calculated: Short Term 1.98b + Long Term 15.97b)
Net Debt = 12.90b USD (from netDebt column, last quarter)
Enterprise Value = 125.20b USD (111.65b + Debt 17.95b - CCE 4.41b)
Interest Coverage Ratio = 2.36 (Ebit TTM 1.37b / Interest Expense TTM 579.6m)
FCF Yield = 2.06% (FCF TTM 2.58b / Enterprise Value 125.20b)
FCF Margin = 28.28% (FCF TTM 2.58b / Revenue TTM 9.14b)
Net Margin = 12.37% (Net Income TTM 1.13b / Revenue TTM 9.14b)
Gross Margin = 38.71% ((Revenue TTM 9.14b - Cost of Revenue TTM 5.60b) / Revenue TTM)
Tobins Q-Ratio = -15.58 (set to none) (Enterprise Value 125.20b / Book Value Of Equity -8.03b)
Interest Expense / Debt = 0.79% (Interest Expense 141.2m / Debt 17.95b)
Taxrate = 0.28% (from yearly Income Tax Expense: 2.70m / 975.6m)
NOPAT = 1.37b (EBIT 1.37b * (1 - 0.28%))
Current Ratio = 4.19 (Total Current Assets 8.29b / Total Current Liabilities 1.98b)
Debt / Equity = 0.50 (Debt 17.95b / last Quarter total Stockholder Equity 35.90b)
Debt / EBITDA = 5.47 (Net Debt 12.90b / EBITDA 3.28b)
Debt / FCF = 6.95 (Debt 17.95b / FCF TTM 2.58b)
Total Stockholder Equity = 33.04b (last 4 quarters mean)
RoA = 2.02% (Net Income 1.13b, Total Assets 55.83b )
RoE = 3.42% (Net Income TTM 1.13b / Total Stockholder Equity 33.04b)
RoCE = 2.79% (Ebit 1.37b / (Equity 33.04b + L.T.Debt 15.97b))
RoIC = 2.80% (NOPAT 1.37b / Invested Capital 48.78b)
WACC = 6.60% (E(111.65b)/V(129.61b) * Re(7.54%)) + (D(17.95b)/V(129.61b) * Rd(0.79%) * (1-Tc(0.00)))
Shares Correlation 5-Years: 100.0 | Cagr: 11.09%
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 80.91% ; FCFE base≈2.21b ; Y1≈2.62b ; Y5≈4.09b
Fair Price DCF = 104.8 (DCF Value 70.08b / Shares Outstanding 668.8m; 5y FCF grow 20.00% → 3.0% )
Revenue Correlation: 96.96 | Revenue CAGR: 21.63%
Rev Growth-of-Growth: 12.70
EPS Correlation: 77.09 | EPS CAGR: 256.4%
EPS Growth-of-Growth: -111.5
Additional Sources for WELL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle